Log in
Enquire now

List of SBIR/STTR awards granted to IMMUNOMEDICS, INC.

List of SBIR/STTR awards granted to IMMUNOMEDICS, INC.
List of SBIR/STTR awards granted to Intelligent Automation, Inc.
List of SBIR/STTR awards granted to Advanced Process Combinatorics, Inc.
List of SBIR/STTR awards granted to Muons, Inc.
List of companies in Samsung's investment portfolio
List of The Ark Sep 2014 companies
where
SBIR/STTR Award Recipient
is
‌
IMMUNOMEDICS, INC.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $887,626.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
2R44CA123985-02A1
Phase II
887,626
sbir.gov/content/dock-and-lock-novel-protein-engineering-2
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $213,982.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA171744-01A1
Phase I
213,982
sbir.gov/node/677620
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $192,688.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA150742-01
Phase I
192,688
sbir.gov/node/1070793
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $1,137,221.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
4R44CA139668-02
Phase II
1,137,221
sbir.gov/node/678600
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $134,285.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43EB003751-01A1
Phase I
134,285
sbir.gov/content/f-18-fdg-peptides-pretargeted-pet-imaging-pancrea-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $114,334.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA114802-01A1
Phase I
114,334
sbir.gov/content/mab-based-targeted-chemotherapy-lung-cancer-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $134,285.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA110297-01
Phase I
134,285
sbir.gov/content/tetravalent-bispecific-fusion-antibody-immunotherapy-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $133,835.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA141754-01
Phase I
133,835
sbir.gov/content/development-interferon-alpha-veltuzumab-conjugate-cd20-targeted-therapy-0
‌
IMMUNOMEDICS, INC. STTR Phase I Award,

A STTR Phase I contract was awarded to IMMUNOMEDICS, INC. for $191,143.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
STTR
1R41AI093082-01
Phase I
191,143
sbir.gov/node/369948
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $200,782.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA180343-01
Phase I
200,782
sbir.gov/node/677678
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA103312-01
Phase I
100,000
sbir.gov/content/minimal-disease-radioimmunotherapy-colorectal-cancer-0
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $964,355.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
2R44CA114802-02
Phase II
964,355
sbir.gov/content/mab-based-targeted-chemotherapy-lung-cancer-2
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $134,285.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA108083-01A2
Phase I
134,285
sbir.gov/content/anti-cd-74-mab-drug-conjugate-b-cell-malignancies-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $119,171.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43EB001515-01
Phase I
119,171
sbir.gov/content/molecular-imaging-affinity-enhancement-pet-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $134,285.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA121468-01A1
Phase I
134,285
sbir.gov/content/novel-rnase-based-immunotoxin-cd74-positive-b-cell-malignancies-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $134,285.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA123985-01
Phase I
134,285
sbir.gov/content/dock-and-lock-novel-protein-engineering-0
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $2,828,870.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
2R44CA141754-02
Phase II
2,828,870
sbir.gov/node/5269
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $1,122,960.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
9R44RR028018-02A1
Phase II
1,122,960
sbir.gov/content/f-18-labeled-peptides-pretargeted-pet-imaging-pancreatic-cancer-0
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $227,025.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA171388-01
Phase I
227,025
sbir.gov/node/400058
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $276,833.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R43CA167897-01
Phase I
276,833
sbir.gov/node/400014
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. for $859,792.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
1R44CA139668-01A1
Phase I
859,792
sbir.gov/content/combined-radio-and-immunotherapy-aggressive-nhl-0
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $802,014.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
2R44CA108083-02A2
Phase II
802,014
sbir.gov/content/anti-cd74-mab-drug-conjugate-b-cell-malignancies-0
‌
IMMUNOMEDICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to IMMUNOMEDICS, INC. for $442,937.0 USD from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
Phase II
442,937
sbir.gov/content/not-available-6253
‌
IMMUNOMEDICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to IMMUNOMEDICS, INC. from the U.S. Department of Health & Human Services.

‌
IMMUNOMEDICS, INC.
SBIR
Phase I
0
sbir.gov/content/not-available-6251
24 results
0 selected
24 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us